159755-11-0

Basic information

• Product Name: 1-bromo-4-(1-bromoethyl)benzene
• Synonyms: 1-bromo-4-(1-bromoethyl)benzene
• CAS NO: 159755-11-0
• Molecular Weight: 263.96
• Mol File: 159755-11-0.mol
• Article Data: 28

Chemical Properties

• CAS DataBase Reference: 1-bromo-4-(1-bromoethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-4-(1-bromoethyl)benzene(159755-11-0)
• EPA Substance Registry System: 1-bromo-4-(1-bromoethyl)benzene(159755-11-0)

Safety Data

• Hazardous Substances Data: 159755-11-0(Hazardous Substances Data)

Upstream product

• 1585-07-5 1-bromo-4-ethylbenzene 
• 1122-91-4 4-bromo-benzaldehyde 
• 2039-82-9 1-bromo-4-ethenyl-benzene 
• 99-90-1 para-bromoacetophenone 
• 24308-78-9 1-(4'-bromophenyl)bromoethane 
• 5391-88-8 1-(4-bromophenyl)ethanol 

Downstream Products

• 59891-97-3 (rac.)-1-bromo-4-(1-methoxyethyl)benzene 
• 29342-35-6 3-Brom-6-nitro-ethylbenzol 
• 293328-14-0 2,2,5-trimethyl-3-(1'-(p-bromo)phenylethoxy)-4-phenyl-3-azahexane 
• 20005-55-4 3-(4-bromophenyl)-1-butanol 
• 31042-07-6 4-(4-bromophenyl)pentanoic acid 
• 86456-68-0 6-bromo-1-methylnaphthalene 
• 86456-56-6 6-bromo-1-naphthaldehyde 
• 86456-66-8 4-(4-bromophenyl)pentanenitrile 
• 86456-65-7 Methanesulfonic acid 3-(4-bromo-phenyl)-butyl ester 
• 86456-62-4 o-<(6-bromo-1-naphthyl)methyl>acetophenone 
• 86456-60-2 o-<(6-bromo-1-naphthyl)methyl>benzoic acid 
• 86456-72-6 2-(6-Bromo-naphthalen-1-ylmethyl)-benzoyl chloride 
• 1003593-01-8 1-[1-(4-bromophenyl)ethoxy]-2,2,6,6-tetraethyl-4-methoxypiperidine 
• 944502-08-3 4-[1-(4-bromo-phenyl)-ethoxy]-1-chloro-2-nitro-benzene 

Relevant articles and documents

Total synthesis of carbazole alkaloids

A Suzuki-Miyaura cross coupling, followed by triphenylphosphine mediated Cadogan reductive cyclization sequence provided efficient access to a series of carbazole alkaloids. In the present work, this approach was applied to the total synthesis of mukonine, clauszoline K, koenoline, murrayanine, murrayafoline A, mukoeic acid, glycoborine, glycozolicine, mukolidine, mukoline, glycozoline, 3-methoxy-9H-carbazole-1-carboxylic acid methyl ester, (3-methoxy-9H-carbazol-1-yl)-methanol, 3-methoxy-9H-carbazole-1-carbaldehyde, 3-methoxy-9H-carbazole-1-carboxylic acid, 2-methyl-9H-carbazole and nonsteroidal anti-inflammatory drug (NSAID) carprofen and its derivatives.

In Situ Generated Gold Nanoparticles on Active Carbon as Reusable Highly Efficient Catalysts for a Csp3 ?Csp3 Stille Coupling

Gold nanoparticle catalysts are important in many industrial production processes. Nevertheless, for traditional Csp2-Csp2 cross-coupling reactions they have been rarely used and Pd catalysts usually give a superior performance. Herein we report that in situ formed gold metal nanoparticles are highly active catalysts for the cross coupling of allylstannanes and activated alkylbromides to form Csp3-Csp3 bonds. Turnover numbers up to 29 000 could be achieved in the presence of active carbon as solid support, which allowed for convenient catalyst recovery and reuse. The present study is a rare case where a gold metal catalyst is superior to Pd catalysts in a cross-coupling reaction of an organic halide and an organometallic reagent.

THERAPEUTIC COMPOUNDS

The present embodiments relate to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition